These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Gadoxetate disodium-related event during image acquisition: a prospective multi-institutional study for better MR practice. Kromrey ML; Hori M; Goshima S; Kozaka K; Hyodo T; Nakamura Y; Nishie A; Tamada T; Shimizu T; Kanki A; Motosugi U Eur Radiol; 2020 Jan; 30(1):281-290. PubMed ID: 31338655 [TBL] [Abstract][Full Text] [Related]
5. Gadoxetate disodium-induced tachypnoea and the effect of dilution method: a proof-of-concept study in mice. Akai H; Yasaka K; Nojima M; Kunimatsu A; Inoue Y; Abe O; Ohtomo K; Kiryu S Eur Radiol; 2018 Feb; 28(2):692-697. PubMed ID: 28894937 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of incidence of acute transient dyspnea and related artifacts after administration of gadoxetate disodium: a prospective observational study. Grazioli L; Faletti R; Frittoli B; Battisti G; Ambrosini R; Romanini L; Gatti M; Fonio P Radiol Med; 2018 Dec; 123(12):910-917. PubMed ID: 30084108 [TBL] [Abstract][Full Text] [Related]
7. Effect of Gadoxetate Disodium on Arterial Phase Respiratory Waveforms Using a Quantitative Fast Fourier Transformation-Based Analysis. Davenport MS; Malyarenko DI; Pang Y; Hussain HK; Chenevert TL AJR Am J Roentgenol; 2017 Feb; 208(2):328-336. PubMed ID: 27929673 [TBL] [Abstract][Full Text] [Related]
8. Intravenous Gadoxetate Disodium Administration Reduces Breath-holding Capacity in the Hepatic Arterial Phase: A Multi-Center Randomized Placebo-controlled Trial. McClellan TR; Motosugi U; Middleton MS; Allen BC; Jaffe TA; Miller CM; Reeder SB; Sirlin CB; Bashir MR Radiology; 2017 Feb; 282(2):361-368. PubMed ID: 27509544 [TBL] [Abstract][Full Text] [Related]
9. Use of Eovist in Pediatric Patients: Pearls and Pitfalls. Shet NS; Flynn JF; Maloney E; Iyer RS Curr Probl Diagn Radiol; 2020; 49(4):266-274. PubMed ID: 31047739 [TBL] [Abstract][Full Text] [Related]
10. An Investigation of Transient Severe Motion Related to Gadoxetic Acid-enhanced MR Imaging. Motosugi U; Bannas P; Bookwalter CA; Sano K; Reeder SB Radiology; 2016 Apr; 279(1):93-102. PubMed ID: 26473642 [TBL] [Abstract][Full Text] [Related]
11. Can gadopentetate dimeglumine be safely administered more rapidly than the FDA-approved injection rate for liver imaging? Shiehmorteza M; Hanna RF; Middleton MS AJR Am J Roentgenol; 2007 Oct; 189(4):W231. PubMed ID: 17885038 [No Abstract] [Full Text] [Related]
12. Matched within-patient cohort study of transient arterial phase respiratory motion-related artifact in MR imaging of the liver: gadoxetate disodium versus gadobenate dimeglumine. Davenport MS; Caoili EM; Kaza RK; Hussain HK Radiology; 2014 Jul; 272(1):123-31. PubMed ID: 24617733 [TBL] [Abstract][Full Text] [Related]
13. Respiratory motion in children and young adults undergoing liver magnetic resonance imaging with intravenous gadoxetate disodium contrast material. Gilligan LA; Trout AT; Anton CG; Schapiro AH; Towbin AJ; Dillman JR Pediatr Radiol; 2019 Aug; 49(9):1171-1176. PubMed ID: 31203405 [TBL] [Abstract][Full Text] [Related]
14. Respiratory-triggered three-dimensional T2-weighted MR cholangiography after injection of gadoxetate disodium: is it still reliable? Ringe KI; Gupta RT; Brady CM; Massey CM; Hahn A; Galanski M; Merkle EM; Lotz J Radiology; 2010 May; 255(2):451-8. PubMed ID: 20413758 [TBL] [Abstract][Full Text] [Related]
16. Gadoxetate disodium-enhanced hepatic MRI: dose-dependent contrast dynamics of hepatic parenchyma and portal vein. Feuerlein S; Boll DT; Gupta RT; Ringe KI; Marin D; Merkle EM AJR Am J Roentgenol; 2011 Jan; 196(1):W18-24. PubMed ID: 21178026 [TBL] [Abstract][Full Text] [Related]
17. Hepatic Arterial Phase in Gadoxetic Acid-Enhanced Liver Magnetic Resonance Imaging: Analysis of Respiratory Patterns and Their Effect on Image Quality. Park YS; Lee CH; Yoo JL; Kim IS; Kiefer B; Woo ST; Kim KA; Park CM Invest Radiol; 2016 Feb; 51(2):127-33. PubMed ID: 26418367 [TBL] [Abstract][Full Text] [Related]
18. Dose-toxicity relationship of gadoxetate disodium and transient severe respiratory motion artifact. Davenport MS; Bashir MR; Pietryga JA; Weber JT; Khalatbari S; Hussain HK AJR Am J Roentgenol; 2014 Oct; 203(4):796-802. PubMed ID: 25055154 [TBL] [Abstract][Full Text] [Related]
19. Respiratory-motion artefacts in liver MRI following injection of gadoxetate disodium and gadobenate dimeglumine: an intra-individual comparative study in cirrhotic patients. Furlan A; Close ON; Borhani AA; Wu YH; Heller MT Clin Radiol; 2017 Jan; 72(1):93.e1-93.e6. PubMed ID: 27633725 [TBL] [Abstract][Full Text] [Related]
20. Nephrogenic systemic fibrosis risk after liver magnetic resonance imaging with gadoxetate disodium in patients with moderate to severe renal impairment: results of a prospective, open-label, multicenter study. Lauenstein T; Ramirez-Garrido F; Kim YH; Rha SE; Ricke J; Phongkitkarun S; Boettcher J; Gupta RT; Korpraphong P; Tanomkiat W; Furtner J; Liu PS; Henry M; Endrikat J Invest Radiol; 2015 Jun; 50(6):416-22. PubMed ID: 25756684 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]